Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac. - Wikidata - awgldk - TriplyDB

Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.

Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.

http://www.wikidata.org/entity/Q34707962

about

Epidemiology of Neisseria meningitidis infections: case distribution by age and relevance of carriage A Novel Loop-Mediated Isothermal Amplification Assay for Serogroup Identification of Neisseria meningitidis in Cerebrospinal Fluid Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years.Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali.Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa A meningococcal NOMV-FHbp vaccine for Africa elicits broader serum bactericidal antibody responses against serogroup B and non-B strains than a licensed serogroup B vaccine Pharyngeal carriage of Neisseria species in the African meningitis belt.Persistence of the immune response after MenACWY-CRM vaccination and response to a booster dose, in adolescents, children and infants Serogroup A meningococcal conjugate vaccines in Africa.An unwanted guest: Neisseria meningitidis - carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence.Fighting Neisseria meningitidis: past and current vaccination strategies.Analysis of novel meningococcal vaccine formulations.Human Complement Bactericidal Responses to a Group A Meningococcal Conjugate Vaccine in Africans and Comparison to Responses Measured by 2 Other Group A Immunoassays.Impact of serogroup A meningococcal conjugate vaccine for Africa.Meningococcal carriage within households in the African meningitis belt: A longitudinal pilot study.Increase of Neisseria meningitidis W:cc11 invasive disease in Chile has no correlation with carriage in adolescents.Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa.Household transmission of Neisseria meningitidis in the meningitis belt.Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature.Molecular characterization of invasive meningococcal isolates in Burkina Faso as the relative importance of serogroups X and W increases, 2008-2012 Progress in Vaccine-Preventable and Respiratory Infectious Diseases-First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006-2015

P2860

Q26770707-B6E40394-79BF-450C-B5E3-7E448E57E653 Q28602719-930E3153-6A45-4426-BAA0-B7BEDBFC7DF5 Q36265032-F25A4E86-0F6F-4D85-94FC-DE464A1FE5F5 Q36265080-9A820DA6-5AF9-40C6-B592-AA2C3793D459 Q36286634-6E256D86-C4C5-46A1-B63C-ED28E52B5AEC Q36521563-9AC6A7B2-9DC6-4845-AC9A-194381020431 Q36934747-46B3555A-999A-40FE-9CF9-7B62C8373567 Q37131083-ACE5DBB5-A9BC-491B-90B1-80CDBCEE2A0D Q38584375-A004E6CD-C2DC-477E-ABD9-D143A92E6D90 Q38775024-85953E90-51B5-43E8-B092-9BD86E96DE1E Q38829564-CC57A720-28B9-405B-ACB9-358D595F8627 Q38844408-F7B5C6A9-8366-46C4-99A7-E03384C2FA28 Q38944335-2020BE7A-AD32-4A0F-8F57-089AF3343ED2 Q46901358-69008595-4ABE-4951-B7D5-4E82B8B79268 Q49347206-AB885B33-0AB2-471B-A49C-84303EA67C97 Q51742865-AEBC2F83-8964-42FD-93F1-998EADE2AA8D Q53685199-F89D3596-6B10-44B9-BB6B-35EF5BFFE2F6 Q54538326-98289B58-71C9-4EDC-BB43-55B3253A2E78 Q55303290-8686C5E0-D901-4C88-BB1B-2861BFE83D69 Q56335519-6E234D4C-56FE-40FC-9709-07AD58E6623A Q56999527-5E5258FF-6AAC-45F4-A329-6AA437B39233

P2860

Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.

http://www.wikidata.org/entity/Q34707962

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Persistent low carriage of ser ...... conjugate vaccine, MenAfriVac.

@ast

Persistent low carriage of ser ...... conjugate vaccine, MenAfriVac.

@en

Persistent low carriage of ser ...... conjugate vaccine, MenAfriVac.

@nl

type

label

Persistent low carriage of ser ...... conjugate vaccine, MenAfriVac.

@ast

Persistent low carriage of ser ...... conjugate vaccine, MenAfriVac.

@en

Persistent low carriage of ser ...... conjugate vaccine, MenAfriVac.

@nl

prefLabel

Persistent low carriage of ser ...... conjugate vaccine, MenAfriVac.

@ast

Persistent low carriage of ser ...... conjugate vaccine, MenAfriVac.

@en

Persistent low carriage of ser ...... conjugate vaccine, MenAfriVac.

@nl

P1433

Q34707962-858539C6-F78C-4A87-B670-FFB5CD12CB3F

P1476

Q34707962-CC88D03E-488D-4E0D-9ABF-85F254FAEEFB

P2093

Q34707962-0D61863D-9FE8-48D8-BDAD-966A55D13878

Q34707962-10A96642-217A-4D31-8D48-09F809C64361

Q34707962-1CAF3B5A-3552-49B1-B8A4-B03AB86FA530

Q34707962-24CFCF20-339B-4BA2-B1BE-49574798A30B

Q34707962-4EF32380-4AFF-43B6-A7D7-B8C32915445B

Q34707962-5500B352-26B9-4455-B84B-C0515C1D5FFD

Q34707962-5F69484E-7E0D-4FCF-8B17-0FD508FC4E19

Q34707962-6802EC95-878F-47D9-812D-9F1FB2A9882A

Q34707962-79FBA848-31BE-4122-B60A-9CF086C4F95B

Q34707962-7C2923C0-5281-4883-ACEF-F282E15DFA00

P2860

Q34707962-03848D60-A41F-4571-AE61-4F4E04D20893

Q34707962-03EFF674-0B17-4983-B37A-E87DCCD8979C

Q34707962-06E96DB1-1828-4592-92C4-08254A720B77

Q34707962-070DD952-7B84-40FD-90D8-3116F6825A75

Q34707962-0F0B7AFF-5FD2-435D-8998-DC14A63CD3B3

Q34707962-25F6ADF8-2EAF-40AE-AC1F-CBFBA38FCA0E

Q34707962-2B81CA84-6F4B-48CC-83F0-BE82202358D6

Q34707962-2DC85DA1-84EB-41D7-8585-21AA1BCFFA86

Q34707962-2EE581EB-FB3C-433D-B712-9BF12BEB26E9

Q34707962-34857F16-B466-42A9-99AE-283520A674AA

P2888

Q34707962-F8AE95FD-DBCD-44B1-B3D0-58FA632AB800

P304

Q34707962-DEDA8E95-3007-4DDF-96E6-3AA7E54E15E3

P31

Q34707962-5E4D17EC-2B3A-4DD4-9A7E-820212D3D807

P356

Q34707962-BE67456D-AEFC-4682-AAC6-B5F046C9D736

P478

Q34707962-266A8B9E-CEA1-48F2-9783-FDDA0229165D

P50

Q34707962-7A11ADC5-1E71-489A-93B4-30B46A3DB95A

P577

Q34707962-34CF3D4D-B538-461A-9C53-BA3B9EDC6F99

P5875

Q34707962-FD7D82E2-6B03-4D70-8D8C-C959AE8F3BC1

P698

Q34707962-60555521-A87A-4D2E-92A1-DD24AE64DAE2

P921

Q34707962-B1B81324-041C-4F0B-8F85-50E1D38930D0

P932

Q34707962-D2750153-2BD5-43F5-913D-7CC7F0935AFB

P356

S12879-014-0663-4

P1433

BMC Infectious Diseases

P1476

Persistent low carriage of ser ...... conjugate vaccine, MenAfriVac.

@en

P2093

Abdoul-Salam Ouédraogo

http://www.w3.org/2001/XMLSchema#string

Absatou Ky Ba

http://www.w3.org/2001/XMLSchema#string

Denis Kandolo

http://www.w3.org/2001/XMLSchema#string

Dominique A Caugant

http://www.w3.org/2001/XMLSchema#string

Fabien Diomandé

http://www.w3.org/2001/XMLSchema#string

Idrissa Sanou

http://www.w3.org/2001/XMLSchema#string

Inger Marie Saga

http://www.w3.org/2001/XMLSchema#string

Lara Misegades

http://www.w3.org/2001/XMLSchema#string

Marie-Pierre Préziosi

http://www.w3.org/2001/XMLSchema#string

Paul A Kristiansen

http://www.w3.org/2001/XMLSchema#string

P2860

Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine

CEREBROSPINAL MENINGITIS IN AFRICA

Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms

Neisseria meningitidis: an overview of the carriage state

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].

Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana.

Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway.

Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis.

Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes

Genetic study of capsular switching between Neisseria meningitidis sequence type 7 serogroup A and C strains

P2888

s12879-014-0663-4

P304

663

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12879-014-0663-4

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Lassana Sangaré

P577

2014-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274892778

http://www.w3.org/2001/XMLSchema#string

P698

25472422

http://www.w3.org/2001/XMLSchema#string

P921

Neisseria meningitidis

P932

4267149

http://www.w3.org/2001/XMLSchema#string